Unresectable colorectal cancer can be cured with multimodality therapy

Annals of Surgery

Volumn 248, Issue 4, 2008, Pages 592-598

  Mathis, Kellie L ^a   Nelson, Heidi ^a   Pemberton, John H ^a   Haddock, Michael G ^a   Gunderson, Leonard L ^b  

^a Division of Colon and Rectal Surgery   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL MORTALITY; URETER OBSTRUCTION; CANCER STAGING; COLON RESECTION; COLONOSCOPY; COLORECTAL TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DRUG CONTRAINDICATION; ENDOSCOPIC ECHOGRAPHY; FOLLOW UP; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLECTOMY; COLONOSCOPY; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; ENDOSONOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UNITED STATES;

EID: 55449115975     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318187ed4a     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Devine RM, Dozois RR. Surgical management of locally advanced adenocarcinoma of the rectum. World J Surg. 1992;16:486-489.
3. Izbicki JR, Hosch SB, Knoefel WT, et al. Extended resections are beneficial for patients with locally advanced colorectal cancer. Dis Colon Rectum. 1995; 38:1251-1256.
4. Wang Y, Cummings B, Catton P, et al. Primary radical external beam radiotherapy of rectal adenocarcinoma: long term outcome of 271 patients. Radiother Oncol. 2005;77:126-132.
5. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
6. Cox DR. Statistical significance tests. Br J Clin Pharmacol. 1982;14:325-331.
7. Gunderson LL, Nelson H, Martenson JA, et al. Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation +/- 5-FU. Int J Radiat Oncol Biol Phys. 1997;37:601-614.
8. National Cancer Institute CTEP. Common Terminology Criteria for Adverse Events v 3.0 (CTCAE). Available at: http://ctep.cancer.gov/forms/CTCAEv3.pdf. Accessed April 21, 2008.
9. Schild SE, Gunderson LL, Haddock MG, et al. The treatment of locally advanced colon cancer. Int J Radiat Oncol Biol Phys. 1997;37:51-58.
10. Nuyttens JJ, Kolkman- Deurloo IK, Vermaas M, et al. High-dose-rate intraoperative radiotherapy for close or positive margins in patients with locally advanced or recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 2004;58:106-112.
11. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343-2351.
12. Kuebler JP, Wieand HS, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol. 2007;25:2198-2204.
13. Tabernero J, Van Cutsem E, Diaz- Rubio E, et al. Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first line treatment of metastatic colorectal cancer. J Clin Oncol. 2007;25:5225-5232.
14. Sadahiro S, Suzuki T, Ishikawa K, et al. Preoperative radio/chemo- radiotherapy in combination with intraoperative radiotherapy for T3- 4Nx rectal cancer. Eur J Surg Oncol. 2004;30:750-758.
15. Willett CG, Shellito PC, Tepper JE, et al. Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma. J Clin Oncol. 1991;9:843-849.
16. Harrison LB, Minsky BD, Enker WE, et al. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 1998;42:325-330.
17. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
18. Gunderson LL, Nelson H, Martenson JA, et al. Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer. Dis Colon Rectum. 1996;39:1379-1395.
19. Haddock MG, Gunderson LL, Nelson H, et al. Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients. Int J Radiat Oncol Biol Phys. 2001;49:1267-1274.
20. Lybeert ML, Martijn H, de Neve W, et al. Radiotherapy for locoregional relapses of rectal carcinoma after initial radical surgery: definite but limited influence on relapse-free survival and survival. Int J Radiat Oncol Biol Phys. 1992;24:241-246.
21. Gunderson LL, Cohen AM, Welch CE. Residual, inoperable or recurrent colorectal cancer. Interaction of surgery and radiotherapy. Am J Surg. 1980;139:518 -525.